13F filer · CIK 923093 ↗
Tudor Investment
You are looking at Q2 2019. See the latest, Q2 2026 →
Reported value
$3.51B
+45% on the quarter before
Positions
1,064
421 new · 431 sold out
Top 10
41.6%
of the value
Est. gain
+$19.5M
on stocks held all quarter
Est. return
+1.8%
on those stocks since Q1 2019
Positions as of Jun 30, 2019, from Tudor Investment's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 50% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2019. Striped tiles are options.
Largest buys
Since Q1 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrustPUT~$602.2MAdded · 2.8% → 19.1%+2,055,100 underlying
- Ishares Msci Emerging Markets - ETF~$190.3MAdded · 1.7% → 6.6%+4,435,683 shares
- SPDR S&P 500 ETF TrustCALL~$104.2MAdded · 0.7% → 3.5%+355,600 underlying
- Anadarko Petroleum Corporation~$60.5MAdded · 0.1% → 1.8%+857,191 shares
- Suntrust Banks Inc~$51.7MAdded · 0.5% → 1.9%+822,716 shares
- Tableau Software Inc-Cl A~$44.0MAdded · 0.3% → 1.5%+265,270 shares
- Worldpay Inc - Cl A~$42.7MAdded · 0.7% → 1.7%+348,538 shares
- Allergan Plc~$36.9MAdded · 0.3% → 1.3%+220,423 shares
- Cray Inc.~$22.3MAdded · 0.0% → 0.6%+641,505 shares
- Cisco~$20.9MNew · 0.0% → 0.6%+381,197 shares
Largest sells
Since Q1 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF Trust~$110.3MCut · 4.5% → 0.1%−376,560 shares
- Celgene CorporationPUT~$61.0MCut · 4.5% → 1.3%−660,100 underlying
- Twenty-First Century Fox Inc - Cl APUT~$36.3MSold out · 1.5% → 0.0%−730,000 underlying
- Takeda Pharmaceutic-Sp ADR~$26.1MSold out · 1.1% → 0.0%−1,279,098 shares
- Twenty-First Century Fox Inc - Cl ACALL~$25.6MSold out · 1.1% → 0.0%−515,000 underlying
- Hanger Inc~$17.0MCut · 0.7% → 0.0%−886,683 shares
- Intel~$15.7MCut · 0.8% → 0.0%−327,935 shares
- Medequities Realty Trust Inc~$14.5MSold out · 0.6% → 0.0%−1,300,000 shares
- Kar Auction Services Inc~$11.2MSold out · 0.5% → 0.0%−218,494 shares
- Clementia Pharmaceuticals In~$10.8MSold out · 0.4% → 0.0%−412,077 shares
Holdings
As of Jun 30, 2019. Changes are in shares against Mar 31, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPDR S&P 500 ETF TrustPUTCOMMON STOCK · shares +865% | 19.1% | $671.7M | — | ||||||||
| Ishares Msci Emerging Markets - ETFCOMMON STOCK · shares +457% · price −0.0% | 6.6% | $232.0M | −$9,255 | ||||||||
| SPDR S&P 500 ETF TrustCALLCOMMON STOCK · shares +570% | 3.5% | $122.5M | — | ||||||||
| Celgene CorporationCOMMON STOCK · shares −6.9% · price −2.0% | 3.0% | $103.6M | −$2.1M | ||||||||
| Suntrust Banks IncCOMMON STOCK · shares +373% · price +6.1% | 1.9% | $65.6M | +$794,325 | ||||||||
| Anadarko Petroleum CorporationCOMMON STOCK · shares +1,590% · price +55.1% | 1.8% | $64.3M | +$1.4M | ||||||||
| Worldpay Inc - Cl ACOMMON STOCK · shares +247% · price +8.0% | 1.7% | $60.0M | +$1.3M | ||||||||
| Tableau Software Inc-Cl ACOMMON STOCK · shares +547% · price +30.4% | 1.5% | $52.1M | +$1.9M | ||||||||
| Celgene CorporationPUTCOMMON STOCK · shares −57% | 1.3% | $45.5M | — | ||||||||
| Allergan PlcCOMMON STOCK · shares +507% · price +14.4% | 1.3% | $44.2M | +$913,958 | ||||||||
| Walt Disney Company (The)COMMON STOCK · shares +4.2% · price +25.8% | 1.1% | $37.8M | +$7.4M | ||||||||
| MicrosoftCOMMON STOCK · shares +15% · price +13.6% | 0.98% | $34.3M | +$3.6M | ||||||||
| Ishares Jp Morgan Usd Emerging Markets Bond ETFCOMMON STOCK · shares 0% · price +2.9% | 0.92% | $32.2M | +$917,000 | ||||||||
| Cray Inc.COMMON STOCK · shares +7,105% · price +33.8% | 0.65% | $22.7M | +$79,395 | ||||||||
| CiscoCOMMON STOCK · shares New | 0.59% | $20.9M | — | ||||||||
| Bristol Myers Squibb CompanyCALLCOMMON STOCK · shares 0% | 0.53% | $18.6M | — | ||||||||
| Ishares Tips Bond ETFCOMMON STOCK · shares +13% · price +2.1% | 0.51% | $17.9M | +$331,301 | ||||||||
| Slack Technologies Inc- Cl ACOMMON STOCK · shares New | 0.51% | $17.8M | — | ||||||||
| Array Biopharma IncCOMMON STOCK · shares New | 0.49% | $17.2M | — | ||||||||
| Aratana Therapeutics IncCOMMON STOCK · shares +4,110% · price +43.3% | 0.47% | $16.4M | +$117,716 | ||||||||
| SalesforceCOMMON STOCK · shares +442% · price −4.2% | 0.42% | $14.7M | −$118,418 | ||||||||
| Ipath Series B S&P 500 VixPUTCOMMON STOCK · shares New | 0.42% | $14.6M | — | ||||||||
| AmazonCOMMON STOCK · shares +29% · price +6.3% | 0.41% | $14.2M | +$656,875 | ||||||||
| Etsy IncCOMMON STOCK · shares New | 0.37% | $13.1M | — | ||||||||
| Allison Transmission HoldingCOMMON STOCK · shares +110% · price +3.2% | 0.36% | $12.5M | +$182,844 | ||||||||
| Total · 1,064 positions | 100% | $3.51B | +$19.5M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2019 to Q2 2019: 636 stocks held throughout, up $19.5M (+1.8%).
- Walt Disney Company (The)+$7.4M+26%
- Microsoft+$3.6M+14%
- Tableau Software Inc-Cl A+$1.9M+30%
- Cme Group Inc+$1.8M+18%
- Alteryx Llc - A+$1.6M+30%
- Occidental Petroleum Corp−$970,469−24%
- Gamestop Corporation−$1.2M−46%
- Simon Property Group Incorporated−$1.6M−12%
- Mallinckrodt Plc−$1.9M−58%
- Celgene Corporation−$2.1M−2%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $71.91B+33% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $53.87B−0% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $54.03B−7% | SEC ↗ |
| Q3 2025 | Dec 9, 2025 (amended) | $57.98B+26% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $45.92B+53% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $30.10B+15% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $26.28B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.48B+41% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $19.52B+24% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $15.72B+27% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $12.42B+25% | SEC ↗ |
| Q3 2023 | Nov 15, 2023 | $9.97B+19% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $8.38B+30% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $6.46B+28% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $5.06B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $4.63B+22% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $3.81B−11% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $4.27B−29% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $5.98B−3% | SEC ↗ |
| Q3 2021 | Nov 17, 2021 (amended) | $6.16B+16% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $5.29B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $4.99B+41% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $3.54B+54% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $2.30B+14% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $2.02B+81% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $1.12B−50% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $2.23B−23% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $2.91B−17% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $3.51B+45% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $2.42B−52% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $5.06B+27% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $3.98B+38% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.87B−7% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $3.09B−22% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $3.94B+0% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $3.92B+19% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $3.28B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $3.25B−16% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $3.88B−9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $4.27B−10% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $4.72B+21% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $3.91B | SEC ↗ |